About Us
CLL Global Research Foundation was founded by patients and families affected by chronic lymphocytic leukemia (CLL) who recognized the urgent need to accelerate research and improve outcomes.
Our mission is to advance the understanding, treatment, and ultimately the cure of CLL—bringing meaningful progress to patients as quickly as possible. We focus on funding innovative research with the potential to translate rapidly into clinical impact, helping move promising ideas from the lab to patients faster.
CLL Global plays a unique role in the research ecosystem. We complement traditional funding sources by supporting early, high-impact projects that can lead to larger-scale funding and broader advances in the field.
Our Community
Our progress is made possible by a powerful partnership between patients, families, donors, and the scientific community.
- Supporters and donors make this work possible by investing in research that directly impacts patients’ lives and by helping raise awareness of CLL.
- Researchers and clinicians bring the expertise, innovation, and dedication needed to advance new treatments and improve care.
- Patients and families are at the heart of everything we do—driving urgency, inspiring innovation, and helping shape research priorities.
Our Commitment
We are committed to bringing together all parts of the CLL community to accelerate progress. By supporting bold ideas, fostering collaboration, and keeping patients at the center of every decision, we aim to turn today’s research into tomorrow’s cures.
Read more: CLL Global’s Beginnings: from concept to reality
—-
Incorporated in the State of Texas, CLL Global is exempt from federal income taxes under Section 501 (c)(3) of the Internal Revenue Code and is classified as a public charity. Contributions to CLL Global Research Foundation are tax-deductible.